179 related articles for article (PubMed ID: 18271962)
1. Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study.
Dumeaux V; Børresen-Dale AL; Frantzen JO; Kumle M; Kristensen VN; Lund E
Breast Cancer Res; 2008; 10(1):R13. PubMed ID: 18271962
[TBL] [Abstract][Full Text] [Related]
2. A new statistical method for curve group analysis of longitudinal gene expression data illustrated for breast cancer in the NOWAC postgenome cohort as a proof of principle.
Lund E; Holden L; Bøvelstad H; Plancade S; Mode N; Günther CC; Nuel G; Thalabard JC; Holden M
BMC Med Res Methodol; 2016 Mar; 16():28. PubMed ID: 26944545
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis.
Waaseth M; Bakken K; Dumeaux V; Olsen KS; Rylander C; Figenschau Y; Lund E
BMC Womens Health; 2008 Jan; 8():1. PubMed ID: 18194511
[TBL] [Abstract][Full Text] [Related]
4. Cohort profile: The Clinical and Multi-omic (CAMO) cohort, part of the Norwegian Women and Cancer (NOWAC) study.
Delgado AB; Tylden ES; Lukic M; Moi L; Busund LR; Lund E; Olsen KS
PLoS One; 2023; 18(2):e0281218. PubMed ID: 36745618
[TBL] [Abstract][Full Text] [Related]
5. Global blood gene expression profiles following a breast cancer diagnosis-Clinical follow-up in the NOWAC post-genome cohort.
Olsen KS; Holden M; Thalabard JC; Rasmussen Busund LT; Lund E; Holden L
PLoS One; 2021; 16(3):e0246650. PubMed ID: 33684121
[TBL] [Abstract][Full Text] [Related]
6. Overdiagnosis of breast cancer in the Norwegian Breast Cancer Screening Program estimated by the Norwegian Women and Cancer cohort study.
Lund E; Mode N; Waaseth M; Thalabard JC
BMC Cancer; 2013 Dec; 13():614. PubMed ID: 24377727
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
Moi L; Braaten T; Al-Shibli K; Lund E; Busund LR
J Transl Med; 2019 Oct; 17(1):334. PubMed ID: 31581940
[TBL] [Abstract][Full Text] [Related]
8. The blood transcriptome prior to ovarian cancer diagnosis: A case-control study in the NOWAC postgenome cohort.
Jareid M; Snapkov I; Holden M; Busund LR; Lund E; Nøst TH
PLoS One; 2021; 16(8):e0256442. PubMed ID: 34449791
[TBL] [Abstract][Full Text] [Related]
9. No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study.
Lund E; Nakamura A; Thalabard JC
Eur J Cancer; 2018 Jan; 89():102-112. PubMed ID: 29245077
[TBL] [Abstract][Full Text] [Related]
10. Gene expression in blood reflects smoking exposure among cancer-free women in the Norwegian Women and Cancer (NOWAC) postgenome cohort.
Baiju N; Sandanger TM; Sætrom P; Nøst TH
Sci Rep; 2021 Jan; 11(1):680. PubMed ID: 33436844
[TBL] [Abstract][Full Text] [Related]
11. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study.
Bakken K; Alsaker E; Eggen AE; Lund E
Int J Cancer; 2004 Oct; 112(1):130-4. PubMed ID: 15305384
[TBL] [Abstract][Full Text] [Related]
13. Deciphering normal blood gene expression variation--The NOWAC postgenome study.
Dumeaux V; Olsen KS; Nuel G; Paulssen RH; Børresen-Dale AL; Lund E
PLoS Genet; 2010 Mar; 6(3):e1000873. PubMed ID: 20300640
[TBL] [Abstract][Full Text] [Related]
14. The ANDROMEDA prospective cohort study: predictive value of combined criteria to tailor breast cancer screening and new opportunities from circulating markers: study protocol.
Giordano L; Gallo F; Petracci E; Chiorino G; Segnan N;
BMC Cancer; 2017 Nov; 17(1):785. PubMed ID: 29166878
[TBL] [Abstract][Full Text] [Related]
15. Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study.
Busund M; Bugge NS; Braaten T; Waaseth M; Rylander C; Lund E
Int J Cancer; 2018 Jun; 142(11):2293-2302. PubMed ID: 29349773
[TBL] [Abstract][Full Text] [Related]
16. Physical activity and blood gene expression profiles: the Norwegian Women and Cancer (NOWAC) Post-genome cohort.
Olsen KS; Lukic M; Borch KB
BMC Res Notes; 2020 Jun; 13(1):283. PubMed ID: 32527328
[TBL] [Abstract][Full Text] [Related]
17. Coffee consumption and the risk of cancer in the Norwegian Women and Cancer (NOWAC) Study.
Lukic M; Licaj I; Lund E; Skeie G; Weiderpass E; Braaten T
Eur J Epidemiol; 2016 Sep; 31(9):905-16. PubMed ID: 27010635
[TBL] [Abstract][Full Text] [Related]
18. Each pregnancy linearly changes immune gene expression in the blood of healthy women compared with breast cancer patients.
Lund E; Nakamura A; Snapkov I; Thalabard JC; Olsen KS; Holden L; Holden M
Clin Epidemiol; 2018; 10():931-940. PubMed ID: 30123005
[TBL] [Abstract][Full Text] [Related]
19. Dietary patterns and lifestyle factors in the Norwegian EPIC cohort: the Norwegian Women and Cancer (NOWAC) study.
Engeset D; Alsaker E; Ciampi A; Lund E
Eur J Clin Nutr; 2005 May; 59(5):675-84. PubMed ID: 15785773
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
